Action Alert – Funding for Key Breast Cancer Research about to End

Help us express our strong support for the Congressionally-Directed Medical Research Program (CDMRP) at the U.S. Department of Defense (DoD).

Since 1992, the CDMRP has strengthened and transformed healthcare for service members and the American public through innovative and impactful biomedical research. Between 1992 and 2017, Congress has, on a bipartisan basis, provided the CDMRP with $11.9 billion in funding to fill militaryrelevant research gaps by supporting high impact, high risk, and high gain projects that other agencies and private investors may be unwilling to fund.

CDMRP funding has resulted in important medical breakthroughs that have improved and enhanced the quality of life for our service members, including groundbreaking technological advancements in prosthetics and transplantations for combat-wounded veterans. In addition, CDMRP research has saved countless lives through the discovery of new treatments and cures to fight cancer and debilitating neurological diseases.

ALERT!!         ALERT!!         ALERT!! 

The Senate unanimously voted to include the language that would not provide funding for all Congressionally-Directed Medical Research Programs which would include the Department of Defense Breast Cancer Research Program.  Below is an Action Alert for the House of Representatives to sign a Dear Colleague letter calling for excluding the language.

House of Representatives leaders are now circulating their Dear Colleague letter calling for excluding the language that is harmful to the DOD BCRP and all Congressionally-Directed Medical Research Programs (CDMRPs)! 

The bipartisan letter, led by Representatives Costello (R-PA), King (R-NY), Loebsack (D-IA), and Bishop (D-GA), will be sent to the Chairmen and Ranking Members of the House and Senate Armed Services Committees and requests that the final National Defense Authorizing Act (NDAA) Conference Report legislation excludes the four harmful provisions in the Senate-passed FY2018 NDAA. 

Action needed: We need our entire network calling their Representatives to urge them to sign the letter. These Representatives are the key targets because they signed the FY 2018 DOD BCRP Appropriations letter in support of the DOD Breast Cancer Research Program and therefore should be willing to sign this letter also. Call these members and give them the message below:

Rep. Vincente Gonzalez-202-225-2531

Rep. Beto O’Rourke-202-225-4831

Rep. Will Hurd-202-225-4511

Rep. Roger Williams-202-225-9896

Rep. Edie Bernice Johnson-202-225-8885

Rep. Pete Sessions-202-225-2231

Rep. Marc Veasey-202-225-9897

Rep. Fileman Vela-202-225-9901

Rep. Lloyd Doggett-202-225-4865


I urge you to show your support for ending breast cancer by signing onto the Costello/King/Loebsack/Bishop Letter to the House and Senate Armed Services Chairmen and Ranking Members requesting that the final NDAA Conference Report legislation excludes the four provisions in the Senate-passed FY2018 NDAA (Sections 733, 891, 892, and 893). To sign the letter, please contact Elle Ciapciak in Rep. Costello’s office, Deena Tauster in Rep. King’s office, Maddie Bushnell in Rep. Loebsack’s office or Patrick Newbold in Rep. Bishop’s office.  


Thank you for this important advocacy action to save the DOD BCRP